ReviewLife (Basel, Switzerland)2026

Obinutuzumab Versus Rituximab for the Treatment of Primary Membranous Nephropathy: A Systematic Review and Meta-Analysis.

Andrew Lurie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.